Foley Partner and chair of the Securities, Commodities & Exchange Regulation Practice George Simon was quoted in an article titled “Unorthodox products get a health warning” in the June 28, 2009 issue of Financial Times. Simon discusses a notice issued by the Financial Industry Regulatory Authority (Finra) stating that inverse and leveraged ETFs typically are not suitable for retail investors who plan to hold them for more than one trading session. Simon remarked that the notice from Finra was stark in its language and may spell the end of the sector.
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"